Press release
Pharmacogenomics Market Surge: An Evaluation of Growth Factors and Key Trends From 2025 to 2029
Pharmacogenomics Market Size
What Is The Projected Market Size Of The Global Pharmacogenomics Market And Its Growth Rate?
Pharmacogenomics market has experienced unprecedented growth:
• Market size increased from $8.94 billion in 2024 to $9.92 billion in 2025, with a CAGR of 10.9%
• Market growth attributed to economic growth in emerging markets, focus on personalized medicine, and increase in healthcare expenditure
• Projected to grow further to $14.81 billion by 2029 with a CAGR of 10.5%
• Growth in the forecast period can be attributed to the increasing aging population, the rising prevalence of chronic diseases, and increasing demand for cancer treatment
What Is Driving The Growth In The Pharmacogenomics Market?
The growth in the pharmacogenomics market is primarily driven by the rising demand for precision medicine, which offers personalized medical treatments tailored to individual patients' genetics and environment. This is particularly relevant in fields like oncology and genetic diseases. As such, with an anticipated one-third increase in investment from leading pharmaceutical companies over the next five years, demand for precision medicine is set to skyrocket. Moreover, precision medicine offers potential re-calibration of current treatment practices for diseases such as type-2 diabetes, which affects 30 million people in the USA alone.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp
Who Are the Key Players Driving Pharmacogenomics Market Growth?
• Illumina Inc
• Eurofins Scientific
• Myriad Genetics Inc
• PerkinElmer Inc
• Centogene N.V
• Invitae Corporation
• Genomind
• Pacific Biosciences of California Inc
• Oneome LLC
• Admera Health
• MapMyGenome
• Positive Bioscience
• Xcode Life Sciences
• Xcelris Labs
• Takeda Pharmaceutical Company Limited
• Garvan Institute of Medical Research
• 3D Medicines Inc
• Berry Genomics
• BGI
• GenomiCare Biotechnology
• Bayer AG
• GlaxoSmithKline plc (GSK)
• F Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V
• Centro de Genoma e Biologia de Sistemas (CGBS)
• Dasa Group
• Datar Cancer Genetics Limited
• MedGenome Labs
• 23andMe
• Color Genomics
• Pathway Genomics
• Laboratório Richet
• Laboratório Exame
• Genomika Diagnósticos
What Are The Key Trends In The Pharmacogenomics Market?
Major trends shaping the market landscape:
• Launch of genome editing solution for deeper analysis of advanced therapies
• Integration of artificial intelligence (AI) in genomics to analyze genetic data
• Advancements in metagenomics
• Strategic partnerships and collaborations among market players
• Introduction of 3D genomics to study influences on gene expression and function
• New product innovations focusing on infectious diseases and gene editing
• Development of psychotropic pharmacogenomics test for informed decisions
What Are The Segments Of The Global Pharmacogenomics Market?
The global pharmacogenomics market is segmented into:
• Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies
• Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications
• End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users
Which Region Leads The Pharmacogenomics Market?
North America was the biggest region in the pharmacogenomics market in 2024. However, Asia-Pacific is projected to be the fastest-growing region in the forecast period. Other regions covered in the pharmacogenomics market report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.
Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report
What Is Covered In The Pharmacogenomics Market Global Market Report?
- Market Size Analysis: Analyze the Pharmacogenomics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pharmacogenomics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pharmacogenomics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pharmacogenomics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/customise?id=7072&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Surge: An Evaluation of Growth Factors and Key Trends From 2025 to 2029 here
News-ID: 3838993 • Views: …
More Releases from The Business Research Company
Rise In Mergers And Acquisitions Fueling The Growth Of The Market Due To Growing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Business Valuation Service Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there's been considerable growth in the business valuation service market size. The market is projected to increase from $7.42 billion in 2024 to approximately $8.05 billion in 2025, with a compound…
Construction Skips Industry Outlook 2025-2029: Market Set to Cross $2.17 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Construction Skips Market Size By 2025?
The market for construction skips has witnessed significant expansion in the past few years. The market is projected to rise from $1.47 billion in 2024 to reach $1.59 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Steady Expansion Forecast for Building Pest Control Services Market, Projected t …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Building Pest Control Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for building pest control services has significantly expanded in previous years. The sector, valued at $20.21 billion in 2024, is projected to increase to $21.84 billion in 2025, registering a compound…
Blockchain Distributed Ledger Technology (DLT) In The Financial Sector Market In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Blockchain Distributed Ledger Technology (DLT) In The Financial Sector Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Driven by growing interest and investments in blockchain research from financial institutions, the acceptance of blockchain technology for international payment purposes, the application of distributed ledger technology in…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
